PCVX Sale Disclosure
Dhaliwal Harpreet S. · SEC Form 4 · Filed Aug 5, 2026
Sale
Calculated transaction value
$935.07K
Dhaliwal Harpreet S. Chief Technical Ops Officer
PCVX
Vaxcyte
PCVX
Transaction date
Aug 5, 2026
Public filing date
Aug 5, 2026
Filing lag
Filed same day
PCVX daily price context
Close on/before transaction
$55.92
Aug 5, 2026
Close before public filing
$54.69
Aug 4, 2026
Return since public filing
+6.29%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 17,000 shares @ $55
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001886794-26-000008
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.36M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vaxcyte, Inc. PCVX | Exercise | Aug 5, 2026 | $0 |
| Vaxcyte, Inc. PCVX Current | Sale | Aug 5, 2026 | $935.07K |
| Vaxcyte, Inc. PCVX | Exercise | Aug 5, 2026 | $421.43K |